Endotoxin potentiation of trichothecene-induced lymphocyte apoptosis is mediated by up-regulation of glucocorticoids

Toxicol Appl Pharmacol. 2002 Apr 1;180(1):43-55. doi: 10.1006/taap.2002.9374.

Abstract

Exposure to bacterial endotoxin (lipopolysaccharide, LPS) is quite common and may increase human susceptibility to chemical-induced tissue injury. The purpose of this study was to identify mechanisms by which LPS potentiates lymphoid tissue depletion in B6C3F1 mice exposed to the common food-borne trichothecene mycotoxin, vomitoxin (VT). As demonstrated by DNA fragmentation and flow cytometric analysis, apoptosis in thymus, Peyer's patches, and bone marrow was marked in mice 12 h after administering Escherichia coli LPS (0.1 mg/kg body wt ip) concurrently with VT (12.5 mg/kg body wt po), whereas apoptosis in control mice or mice treated with either toxin alone was minimal. Based on observed increases in tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6 serum concentrations following LPS and VT cotreatment, the roles of these cytokines in apoptosis potentiation were assessed. Injection with rolipram, an inhibitor of TNF-alpha expression, or use of IL-6 knockout mice was ineffective at impairing thymic apoptosis induction by the toxin cotreatment, suggesting that these cytokines did not mediate LPS potentiation. Toxin cotreatment increased splenic cyclooxygenase-2 mRNA expression, suggesting possible involvement of prostaglandins in apoptosis. However, indomethacin, a broad spectrum inhibitor of cyclooxygenases, failed to block thymus apoptosis. Toxin cotreatment increased serum corticosterone and, furthermore, RU 486, a glucocorticoid receptor antagonist, significantly abrogated apoptosis in thymus, Peyer's patches, and bone marrow following LPS + VT exposure. The results presented herein and the known capacity of glucocorticoids to cause apoptosis indicate that hypothalamic-pituitary-adrenal axis plays a key role in LPS potentiation of trichothecene-induced lymphocyte apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Apoptosis / drug effects*
  • Corticosterone / biosynthesis*
  • Corticosterone / blood
  • Cyclooxygenase 2
  • DNA Fragmentation / drug effects
  • Drug Synergism
  • Escherichia coli / immunology
  • Flow Cytometry
  • Indomethacin / pharmacology
  • Interleukin-6 / blood
  • Interleukin-6 / deficiency
  • Interleukin-6 / genetics
  • Isoenzymes / biosynthesis
  • Isoenzymes / genetics
  • Lipopolysaccharides / pharmacology*
  • Lymphocytes / drug effects*
  • Lymphocytes / pathology
  • Lymphoid Tissue / drug effects
  • Lymphoid Tissue / pathology
  • Male
  • Mice
  • Mice, Inbred C3H
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mifepristone / pharmacology
  • Prostaglandin-Endoperoxide Synthases / biosynthesis
  • Prostaglandin-Endoperoxide Synthases / genetics
  • Trichothecenes / toxicity*
  • Tumor Necrosis Factor-alpha / analysis
  • Up-Regulation

Substances

  • Interleukin-6
  • Isoenzymes
  • Lipopolysaccharides
  • Trichothecenes
  • Tumor Necrosis Factor-alpha
  • Mifepristone
  • Cyclooxygenase 2
  • Prostaglandin-Endoperoxide Synthases
  • deoxynivalenol
  • Corticosterone
  • Indomethacin